Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Protecting telomeres prevents lung fibrosis

Oct. 21, 2020

DeltaF508 CFTR cystic fibrosis models generated in Collaborative Cross mice

Oct. 20, 2020

Furin inhibitor BOS-318 seems effective for treating cystic fibrosis

Oct. 19, 2020

New model created for CFTR gene nonsense mutation W1282X cystic fibrosis

Oct. 19, 2020

Avalyn advances phase I/II study of AP-101 in IPF

Oct. 19, 2020

Chitinase-3-like protein 1 identified as cystic fibrosis therapeutic target

Oct. 16, 2020

Investigator-initiated study of IONIS-PKK-LRx in patients with COVID-19 begins

Oct. 16, 2020

Mucolytic agent MUC-031 has beneficial effects in cystic fibrosis model

Oct. 16, 2020

FDA grants expanded access to ExoFlo for COVID-19-associated ARDS

Oct. 14, 2020

Targeting Ire1-alpha may reduce cystic fibrosis airway inflammation

Oct. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...